Cortes JE - Search Results

1

Cortes JE, Talpaz M, Kantarjian H. Cortes JE, et al. Am J Med. 1996 May;100(5):555-70. doi: 10.1016/s0002-9343(96)00061-7. Am J Med. 1996. PMID: 8644769 Review.

2

Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.

Kantarjian H, O'Brien S, Cortes J, Shan J, Giles F, Garcia-Manero G, Verstovsek S, Faderl S, Rios MB, Talpaz M. Kantarjian H, et al. Cancer. 2003 Oct 1;98(7):1430-7. doi: 10.1002/cncr.11665. Cancer. 2003. PMID: 14508830 Free article.

3

Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.

Cortes JE, Talpaz M, Beran M, O'Brien SM, Rios MB, Stass S, Kantarjian HM. Cortes JE, et al. Cancer. 1995 Jan 15;75(2):464-70. doi: 10.1002/1097-0142(19950115)75:2<464::aid-cncr2820750209>3.0.co;2-e. Cancer. 1995. PMID: 7812917

4

Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.

Cortes JE, Kantarjian H, O'Brien S, Keating M, Pierce S, Freireich EJ, Estey E. Cortes JE, et al. Leukemia. 1995 Jan;9(1):115-7. Leukemia. 1995. PMID: 7845005

5

Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy.

Cortes JE, Kantarjian HM. Cortes JE, et al. Cancer. 1995 Dec 15;76(12):2393-417. doi: 10.1002/1097-0142(19951215)76:12<2393::aid-cncr2820761203>3.0.co;2-p. Cancer. 1995. PMID: 8625065 Review.

6

Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemia.

Rodriguez-Monge EJ, Cortes JE, O'Brien S, Talpaz M, Kantarjian HM. Rodriguez-Monge EJ, et al. Among authors: cortes je. Cancer. 1997 Aug 1;80(3):396-400. doi: 10.1002/(sici)1097-0142(19970801)80:3<396::aid-cncr7>3.0.co;2-q. Cancer. 1997. PMID: 9241073

7

Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature.

Aguayo A, Cortes JE, Kantarjian HM, Beran M, Gandhi V, Plunkett W, Kurtzberg J, Keating MJ. Aguayo A, et al. Among authors: cortes je. Cancer. 1999 Jan 1;85(1):58-64. Cancer. 1999. PMID: 9921974 Review.

8

A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission.

Cortes JE, Kantarjian HM, O'Brien S, Giles F, Keating MJ, Freireich EJ, Estey EH. Cortes JE, et al. Cancer. 1999 Apr 1;85(7):1506-13. Cancer. 1999. PMID: 10193940 Review.

9

Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia.

Giles FJ, Cortes JE, Baker SD, Thomas DA, O'Brien S, Smith TL, Beran M, Bivins C, Jolivet J, Kantarjian HM. Giles FJ, et al. Among authors: cortes je. J Clin Oncol. 2001 Feb 1;19(3):762-71. doi: 10.1200/JCO.2001.19.3.762. J Clin Oncol. 2001. PMID: 11157029 Clinical Trial.

10

Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemia.

Gao H, Lee BN, Talpaz M, Donato NJ, Cortes JE, Kantarjian HM, Reuben JM. Gao H, et al. Among authors: cortes je. Leukemia. 2005 Nov;19(11):1905-11. doi: 10.1038/sj.leu.2403933. Leukemia. 2005. PMID: 16151467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

462 results

Search Page

Filters